Flibanserin: A controversial drug for female hypoactive sexual desire disorder

Flibanserin: A controversial drug for female hypoactive sexual desire disorder

Sexual functioning is an integral part of human life. Female sexual dysfunction (FSD) adversely affects quality of life and general well-being. The Food and Drug Administration recently approved flibanserin, for treatment of female hypoactive sexual desire disorder (HSDD), regarded as the most commo...

Full description

Bibliographic Details
Main Authors: Rashmi Baid, Rakesh Agarwal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Industrial Psychiatry Journal
Subjects:
Addyi
female hypoactive sexual desire disorder
flibanserin
Online Access:http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2018;volume=27;issue=1;spage=154;epage=157;aulast=Baid

Internet

http://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2018;volume=27;issue=1;spage=154;epage=157;aulast=Baid

Similar Items